![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1721455
¸¶ÀÌÅ©·Î CT ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м® ¹× ¿¹Ãø(2025-2034³â)Micro Computed Tomography Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
¼¼°èÀÇ ¸¶ÀÌÅ©·Î CT ½ÃÀåÀº 2024³â¿¡ 2¾ï 7,690¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, CAGR 8.2%¸¦ ³ªÅ¸³» 2034³â±îÁö´Â 6¾ï 480¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
¸¶ÀÌÅ©·Î CT´Â ³»ºÎ ±¸Á¶ÀÇ ÃʰíÇØ»óµµ 3D À̹ÌÁö¸¦ Á¦°øÇÏ´Â °·ÂÇÑ À̹Ì¡ ±â¼ú·Î, ŸÀÇ ÃßÁ¾À» ºÒÇãÇÏ´Â Á¤È®¼º°ú ¼¼ºÎ»çÇ×À» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.
¸¶ÀÌÅ©·Î CT ½Ã½ºÅÛÀº ºñÆÄ±« °Ë»ç ±â´ÉÀ» Á¦°øÇϸç Ç×°ø¿ìÁÖ, ÀÚµ¿Â÷, ÀüÀÚ±â±â µî °íµµÀÇ Ç°Áúº¸ÁõÀ» ÇÊ¿ä·Î ÇÏ´Â »ê¾÷¿¡¼ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. Áß¿äÇÑ ¿¬±¸°³¹ß Ȱµ¿À» Áö¿øÇÒ »Ó¸¸ ¾Æ´Ï¶ó ½Å¼ÒÀç¿Í ½ÅÁ¦Ç°ÀÇ »ó¾÷È¿¡ À־µ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§ | |
---|---|
½ÃÀÛ ¿¬µµ | 2024³â |
¿¹Ãø ¿¬µµ | 2025-2034³â |
½ÃÀÛ ±Ý¾× | 2¾ï 7,690¸¸ ´Þ·¯ |
¿¹Ãø ±Ý¾× | 6¾ï 480¸¸ ´Þ·¯ |
CAGR | 8.2% |
óÀ½¿¡´Â ¹ÙÀÌ¿À¸ÞµðÄà ÇコÄɾî À̹Ì¡¿ëÀ¸·Î °³¹ßµÈ ¸¶ÀÌÅ©·Î CT´Â ¿¬¿ùÀ» °ÅÄ¡¸é¼ ±× ÀÀ¿ë ¹üÀ§¸¦ Å©°Ô ³ÐÇô ¿Ô½À´Ï´Ù. Á¦Á¶ ȯ°æ Àüü¿¡ °ÉÃÄ Á¤¹Ð °øÇаú ǰÁú °ü¸®°¡ Áß½ÃµÇ°Ô µÊÀ¸·Î½á ¸¶ÀÌÅ©·Î CT ½Ã½ºÅÛ ¼ö¿ä°¡ ¼¼°è¿¡¼ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.
½ÃÀåÀº Á¦Ç° À¯Çüº°·Î in vivo¿Í ex vivoÀÇ ¸¶ÀÌÅ©·Î CT·Î ±¸ºÐµË´Ï´Ù. Ex vivo ½Ã½ºÅÛÀº ÃßÃâµÈ »ùÇÃÀ» ¸Å¿ì ¼±¸íÇÏ°Ô ½ºÄµÇÒ ¼ö Àֱ⠶§¹®¿¡ Àç·á °úÇÐ, »ý¹°ÇÐ, Çコ Äɾî À̹Ì¡¿¡ ³Î¸® ÀÌ¿ëµÇ°í ÀÖ½À´Ï´Ù.
¸¶ÀÌÅ©·ÎCT´Â »ý¸í°úÇÐ, Ä¡°úÇÐ, »À¿¬±¸, ½Ä¹°¡¤½ÄǰºÐ¼®, Àç·á°úÇÐ, ÁöÁúÇС¤¼®À¯ ¹× °¡½º µî ¸î °¡Áö ÁÖ¿ä ¿ëµµ·Î ÀÌ¿ëµÇ°í ÀÖ½À´Ï´Ù. ¸¶ÀÌÅ©·ÎCT´Â Á¶Á÷°ú Àå±â¸¦ »ó¼¼ÇÏ°í ºñħ½ÀÀûÀ¸·Î 3D·Î ½Ã°¢ÈÇÒ ¼ö Àֱ⠶§¹®¿¡ Á¾¾çÇÐ, ½ÉÀ庴ÇÐ, ½Å°æÇÐ µîÀÇ ºÐ¾ß¿¡¼ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.
¹Ì±¹ÀÇ ¸¶ÀÌÅ©·Î CT ½ÃÀåÀº 2023³â¿¡ 9,750¸¸ ´Þ·¯¸¦ âÃâÇß°í 2034³â±îÁö´Â 2¾ï 2,770¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
°æÀï ±¸µµ¸¦ Çü¼ºÇÏ´Â ÁÖ¿ä ±â¾÷Àº Bruker, PerkinElmer, Zeiss, TESCAN, Shimadzu, Micro Photonics, Rigaku, North Star Imaging, Delta Electronics, NeoScan, SCANCO Medical, Sanying Precision Instruments µîÀÌ ÀÖ½À´Ï´Ù. ÀÌµé ±â¾÷Àº ¿¬±¸°³¹ß¿¡ ¸¹Àº ÅõÀÚ¸¦ ÇÏ°í ¶Ù¾î³ ÇØ»óµµ, º¸´Ù ºü¸¥ ½ºÄµ ¼Óµµ, »ç¿ëÀÚ Ä£ÈÀûÀÎ ±â´ÉÀ» °®Ãá ½Ã½ºÅÛÀ» Æ÷ÇÔÇÑ Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®´ëÇϰí ÀÖ½À´Ï´Ù.
The Global Micro Computed Tomography Market was valued at USD 276.9 million in 2024 and is estimated to grow at a CAGR of 8.2% to reach USD 604.8 million by 2034. Micro computed tomography (micro-CT) is a powerful imaging technology that delivers ultra-high-resolution 3D images of internal structures, enabling unmatched accuracy and detail. The increasing demand for advanced imaging solutions across both industrial and scientific applications is driving substantial growth in this market.
Micro-CT systems offer non-destructive testing capabilities that are especially valuable in industries requiring high levels of quality assurance, such as aerospace, automotive, and electronics. With ongoing technological advancements, including faster scan times, improved resolution, and more compact systems, micro-CT is evolving into a highly versatile tool. It not only supports critical R&D activities but also plays a pivotal role in the commercialization of new materials and products. The integration of AI and machine learning for automated image analysis is further enhancing the efficiency and accuracy of micro-CT systems, making them even more indispensable across diverse sectors.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $276.9 Million |
Forecast Value | $604.8 Million |
CAGR | 8.2% |
Initially developed for biomedical and healthcare imaging, micro-CT has significantly broadened its reach over the years. The ability to visualize microstructures in 3D without damaging the object makes it ideal for use in material science, biology, electronics, and geological research. The growing emphasis on precision engineering and quality control across manufacturing environments is amplifying the demand for micro-CT systems worldwide. Moreover, the surge in pharmaceutical and biotech research, especially in preclinical studies and drug development, has fueled widespread adoption in life sciences.
The market is segmented by product type into in vivo and ex vivo micro-CT. In 2024, the ex vivo micro-CT segment accounted for a dominant 77.2% share. Ex vivo systems are widely used in material science, biology, and healthcare imaging for their ability to scan extracted samples with extreme clarity. These systems are particularly beneficial for researchers who need detailed internal imaging of biological specimens or structural materials without altering or destroying them. The ultra-high-resolution imaging they offer is critical in exploring microscopic details in various applications.
Micro-CT serves several key applications, including life science, dentistry, bone research, plant and food analysis, material science, and geology or oil and gas. In 2024, the life science segment led the market with a 38.2% share. The ability of micro-CT to offer detailed, non-invasive 3D visualization of tissues and organs makes it crucial in fields like oncology, cardiology, and neurology. It supports the entire research lifecycle from hypothesis testing to validation in drug development and disease modeling.
The U.S. Micro Computed Tomography Market generated USD 97.5 million in 2023 and is anticipated to reach USD 227.7 million by 2034. Robust R&D investments, adoption of advanced diagnostic tools, and growing industrial applications continue to drive market expansion in the country.
Key players shaping the competitive landscape include Bruker, PerkinElmer, Zeiss, TESCAN, Shimadzu, Micro Photonics, Rigaku, North Star Imaging, Delta Electronics, NeoScan, SCANCO Medical, and Sanying Precision Instruments. These companies are investing heavily in R&D and expanding their product portfolios to include systems with superior resolution, faster scanning speeds, and user-friendly features. Strategic partnerships with academic institutions and industry stakeholders are also playing a central role in extending their global footprint and enhancing innovation.